These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30964704)

  • 1. Role of exercise-induced hepatokines in metabolic disorders.
    Ennequin G; Sirvent P; Whitham M
    Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E11-E24. PubMed ID: 30964704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatokines-a novel group of exercise factors.
    Weigert C; Hoene M; Plomgaard P
    Pflugers Arch; 2019 Mar; 471(3):383-396. PubMed ID: 30338347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatokines: unlocking the multi-organ network in metabolic diseases.
    Iroz A; Couty JP; Postic C
    Diabetologia; 2015 Aug; 58(8):1699-703. PubMed ID: 26032022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatokines as a Molecular Transducer of Exercise.
    Seo DY; Park SH; Marquez J; Kwak HB; Kim TN; Bae JH; Koh JH; Han J
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33498410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatokines and metabolism: Deciphering communication from the liver.
    Jensen-Cody SO; Potthoff MJ
    Mol Metab; 2021 Feb; 44():101138. PubMed ID: 33285302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between hepatokines and metabolic diseases.
    Liang JQ; Liu C; Zhang WX; Chen SY
    Yi Chuan; 2022 Oct; 44(10):853-866. PubMed ID: 36384723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatokines and non-alcoholic fatty liver disease.
    Lebensztejn DM; Flisiak-Jackiewicz M; Białokoz-Kalinowska I; Bobrus-Chociej A; Kowalska I
    Acta Biochim Pol; 2016; 63(3):459-67. PubMed ID: 27262842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of hepatokines involved in pathology of type 2 diabetes and obesity.
    Misu H
    Endocr J; 2019 Aug; 66(8):659-662. PubMed ID: 31366824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans.
    Peter A; Kovarova M; Staiger H; Machann J; Schick F; Königsrainer A; Königsrainer I; Schleicher E; Fritsche A; Häring HU; Stefan N
    Am J Physiol Endocrinol Metab; 2018 Mar; 314(3):E266-E273. PubMed ID: 29138227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines.
    Oh KJ; Lee DS; Kim WK; Han BS; Lee SC; Bae KH
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of hepatokines in metabolic disorders and cardiovascular diseases.
    Jung TW; Yoo HJ; Choi KM
    BBA Clin; 2016 Jun; 5():108-13. PubMed ID: 27051596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do diabetes and obesity affect the metabolic response to exercise?
    Plomgaard P; Weigert C
    Curr Opin Clin Nutr Metab Care; 2017 Jul; 20(4):294-299. PubMed ID: 28375877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.
    Meex RCR; Watt MJ
    Nat Rev Endocrinol; 2017 Sep; 13(9):509-520. PubMed ID: 28621339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic PTEN Signaling Regulates Systemic Metabolic Homeostasis through Hepatokines-Mediated Liver-to-Peripheral Organs Crosstalk.
    Berthou F; Sobolewski C; Abegg D; Fournier M; Maeder C; Dolicka D; Correia de Sousa M; Adibekian A; Foti M
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hepatokines in NAFLD.
    Stefan N; Schick F; Birkenfeld AL; Häring HU; White MF
    Cell Metab; 2023 Feb; 35(2):236-252. PubMed ID: 36754018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise as a tool to mitigate metabolic disease.
    Esteves JV; Stanford KI
    Am J Physiol Cell Physiol; 2024 Sep; 327(3):C587-C598. PubMed ID: 38981607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.
    Panera N; Della Corte C; Crudele A; Stronati L; Nobili V; Alisi A
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):393-403. PubMed ID: 26654761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.
    Kim TH; Hong DG; Yang YM
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive Sleep Apnea Syndrome and Metabolic Diseases.
    Li M; Li X; Lu Y
    Endocrinology; 2018 Jul; 159(7):2670-2675. PubMed ID: 29788220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes.
    Hansen JS; Pedersen BK; Xu G; Lehmann R; Weigert C; Plomgaard P
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2816-25. PubMed ID: 27163358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.